Deviated balance between Th1 and Th17 cells exacerbates acute graft-versus-host disease in mice

Cytokine

Volumn 68, Issue 2, 2014, Pages 69-75

  Pan, Bin ^a   Zhang, Ying ^a   Sun, Yuqi ^a   Cheng, Hai ^a   Wu, Yujing ^a   Song, Guoliang ^a   Chen, Wei ^a   Zeng, Lingyu ^a   Xu, Kailin ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Graft versus host disease; Th1 cell; Th17 cell

Indexed keywords

GAMMA INTERFERON; HALOFUGINONE; INTERLEUKIN 17; PIPERIDINE DERIVATIVE; QUINAZOLINONE DERIVATIVE;

ACUTE GRAFT VERSUS HOST DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; GRAFT RECIPIENT; IMMUNOLOGICAL PARAMETERS; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; TH1 CELL; TH1 TH17 CELL IMBALANCE; TH17 CELL; UPREGULATION; WEIGHT CHANGE; ACUTE DISEASE; ANIMAL; ANTIBODY SPECIFICITY; BAGG ALBINO MOUSE; C57BL MOUSE; DISEASE COURSE; DRUG EFFECTS; GRAFT VERSUS HOST REACTION; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM;

ACUTE DISEASE; ANIMALS; DISEASE PROGRESSION; GRAFT VS HOST DISEASE; INTERFERON-GAMMA; INTERLEUKIN-17; LYMPHOCYTE COUNT; MICE, INBRED BALB C; MICE, INBRED C57BL; ORGAN SPECIFICITY; PIPERIDINES; QUINAZOLINONES; TH1 CELLS; TH17 CELLS;

EID: 84899667712     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.04.002     Document Type: Article

References (28)

1. Welniak L.A., Blazar B.R., Murphy W.J. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol 2007, 25:139-170.
2. Ferrara J.L., Levine J.E., Reddy P., Holler E. Graft-versus-host disease. Lancet 2009, 373:1550-1561.
3. Blazar B.R., Murphy W.J., Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol 2012, 12:443-458.
4. Lu Y., Sakamaki S., Kuroda H., Kusakabe T., Konuma Y., Akiyama T., et al. Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603. Blood 2001, 97:1123-1130.
5. Carlson M.J., West M.L., Coghill J.M., Panoskaltsis-Mortari A., Blazar B.R., Serody J.S. In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood 2009, 113:1365-1374.
6. Burman A.C., Banovic T., Kuns R.D., Clouston A.D., Stanley A.C., Morris E.S., et al. IFN gamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract. Blood 2007, 110:1064-1072.
7. Yi T., Zhao D., Lin C.L., Zhang C., Chen Y., Todorov I., et al. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood 2008, 112:2101-2110.
8. Cecchinato V., Trindade C.J., Laurence A., Heraud J.M., Brenchley J.M., Ferrari M.G., et al. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol 2008, 1:279-288.
9. Shah K., Lee W.W., Lee S.H., Kim S.H., Kang S.W., Craft J., et al. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthrit Res Ther 2010, 12:R53.
10. Zhou L., Chong M.M., Littman D.R. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009, 30:646-655.
11. Nguyen T.H., Casale T.B. Immune modulation for treatment of allergic disease. Immunol Rev 2011, 242:258-271.
12. Lu T.X., Hartner J., Lim E.J., Fabry V., Mingler M.K., Cole E.T., et al. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol 2011, 187:3362-3373.
13. Yang J., Chu Y., Yang X., Gao D., Zhu L., Yang X., et al. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 2009, 60:1472-1483.
14. Wang J., Pae M., Meydani S.N., Wu D. Green tea epigallocatechin-3-gallate modulates differentiation of naïve CD4(+) T cells into specific lineage effector cells. J Mol Med (Berl) 2013, 91:485-495.
15. Kobayashi T., Okamoto S., Hisamatsu T., Kamada N., Chinen H., Saito R., et al. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 2008, 57:1682-1689.
16. Pan B., Zeng L., Cheng H., Song G., Chen C., Zhang Y., et al. Altered balance between Th1 and Th17 cells in circulation is an indicator for the severity of murine acute GVHD. Immunol Lett 2012, 142:48-54.
17. Sundrud M.S., Koralov S.B., Feuerer M., Calado D.P., Kozhaya A.E., Rhule-Smith A., et al. Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response. Science 2009, 324:1334-1338.
18. Cooke K.R., Kobzik L., Martin T.R., Brewer J., Delmonte J., Crawford J.M., et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 1996, 88:3230-3239.
19. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
20. Reddy P. Pathophysiology of acute graft-versus-host disease. Hematol Oncol 2003, 21:149-161.
21. Kappel L.W., Goldberg G.L., King C.G., Suh D.Y., Smith O.M., Ligh C., et al. IL-17 contributes to CD4-mediated graft-versus-host disease. Blood 2009, 113:945-952.
22. Lu Y., Waller E.K. Dichotomous role of interferon-gamma in allogeneic bone marrow transplant. Biol Blood Marrow Transplant 2009, 15:1347-1353.
23. O'Connor W., Kamanaka M., Booth C.J., Town T., Nakae S., Iwakura Y., et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 2009, 10:603-609.
24. Gnainsky Y., Kushnirsky Z., Bilu G., Hagai Y., Genina O., Volpin H., et al. Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-beta signaling. Cell Tissue Res 2007, 328:153-166.
25. Pines M., Snyder D., Yarkoni S., Nagler A. Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma. Biol Blood Marrow Transplant 2003, 9:417-425.
26. Yu Y., Wang D., Liu C., Kaosaard K., Semple K., Anasetti C., et al. Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice. Blood 2011, 118:5011-5020.
27. Yi T., Chen Y., Wang L., Du G., Huang D., Zhao D., et al. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease. Blood 2009, 114:3101-3112.
28. Mavigner M., Cazabat M., Dubois M., L'Faqihi F.E., Requena M., Pasquier C., et al. Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. J Clin Invest 2012, 122:62-69.